MONSO Stock Overview
Develops and sells digital health solution for the treatment of mental disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Monsenso A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 0.45 |
| 52 Week High | DKK 0.95 |
| 52 Week Low | DKK 0.27 |
| Beta | 2.1 |
| 11 Month Change | -24.37% |
| 3 Month Change | -18.92% |
| 1 Year Change | 43.77% |
| 33 Year Change | -73.53% |
| 5 Year Change | n/a |
| Change since IPO | -93.86% |
Recent News & Updates
Shareholder Returns
| MONSO | DK Healthcare Services | DK Market | |
|---|---|---|---|
| 7D | 0.9% | -3.5% | -2.1% |
| 1Y | 43.8% | -11.6% | 6.2% |
Return vs Industry: MONSO exceeded the Danish Healthcare Services industry which returned -11.9% over the past year.
Return vs Market: MONSO exceeded the Danish Market which returned 4.2% over the past year.
Price Volatility
| MONSO volatility | |
|---|---|
| MONSO Average Weekly Movement | 15.8% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in DK Market | 10.4% |
| 10% least volatile stocks in DK Market | 2.5% |
Stable Share Price: MONSO's share price has been volatile over the past 3 months compared to the Danish market.
Volatility Over Time: MONSO's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 12 | Thomas Lethenborg | www.monsenso.com |
Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, psychoeducation and cognitive behavioral therapy, and secure messaging; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, notes/medical record keeping, messaging, and shared decision-making; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment.
Monsenso A/S Fundamentals Summary
| MONSO fundamental statistics | |
|---|---|
| Market cap | DKK 29.99m |
| Earnings (TTM) | -DKK 5.42m |
| Revenue (TTM) | DKK 10.74m |
2.8x
P/S Ratio-5.5x
P/E RatioIs MONSO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MONSO income statement (TTM) | |
|---|---|
| Revenue | DKK 10.74m |
| Cost of Revenue | DKK 5.59m |
| Gross Profit | DKK 5.15m |
| Other Expenses | DKK 10.57m |
| Earnings | -DKK 5.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.081 |
| Gross Margin | 47.97% |
| Net Profit Margin | -50.44% |
| Debt/Equity Ratio | 0% |
How did MONSO perform over the long term?
See historical performance and comparison